Veracyte
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.About VCYT
Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia.
CEOMarc A. Stapley
CEOMarc A. Stapley
Employees824
Employees824
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2006
Founded2006
Employees824
Employees824
VCYT Key Statistics
Market cap3.42B
Market cap3.42B
Price-Earnings ratio114.04
Price-Earnings ratio114.04
Dividend yield—
Dividend yield—
Average volume754.76K
Average volume754.76K
High today$43.58
High today$43.58
Low today$41.23
Low today$41.23
Open price$41.73
Open price$41.73
Volume572.19K
Volume572.19K
52 Week high$50.71
52 Week high$50.71
52 Week low$22.61
52 Week low$22.61
Stock Snapshot
Veracyte(VCYT) stock is priced at $43.30, giving the company a market capitalization of 3.42B. It carries a P/E multiple of 114.04.
During the trading session on 2026-01-22, Veracyte(VCYT) shares reached a daily high of $43.58 and a low of $41.23. At a current price of $43.30, the stock is +5.0% higher than the low and still -0.6% under the high.
Trading volume for Veracyte(VCYT) stock has reached 572.19K, versus its average volume of 754.76K.
Over the past 52 weeks, Veracyte(VCYT) stock has traded between a high of $50.71 and a low of $22.61.
Over the past 52 weeks, Veracyte(VCYT) stock has traded between a high of $50.71 and a low of $22.61.
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
15.4%
Sell
7.7%
People also own
Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.